Jason Hope is a philanthropist, businessman, and investor. Graduating from Arizona State University, Jason Hope earned his BS degree in Finance. Later, he earned his MBA at W. P. Carey School of Business which is also part of Arizona State University. As a businessman, he created a mobile communications company. Since the founding of his company, Jason Hope now focuses his attention on investing in biotechnology as well as humanitarian efforts.
Today, we take a look at an article dated February 27th, 2018. The article begins with Jason Hope’s enthusiasm on the subject of “anti-aging research”. Fusing his entrepreneurship with philanthropy, he states that “cutting-edge technology can prevent diseases”.
In 2010, Jason Hope donated half a million dollars to the Strategies for Negligible Senescence Research Foundation (SENS) to research techniques that can slow the aging process as well as the effects of aging. The article moves on to talk about how Mr. Hope’s donation will create opportunities for new “strategies” that can make improvements in “health in the mitochondria” and the rejuvenation of aging cells.
Next, the article describes an enzyme called, telomerase. This enzyme is described as, “sections of chromosomes that protect the genetic material within the cells …” If there are great numbers of the telomerase enzyme, it will aid in slowing or preventing the effects of the aging process. Another benefit described in reference to the enzyme can alleviate the risk of conditions related to “chronic inflammation”.
It then talks about medical conditions and briefly discusses dementia. The organization is researching new techniques that can help in the prevention of high levels of inflammatory compounds, which can lead to the development of dementia.
The article moves forward to discuss cells, specifically, senescent cells. These cells are described to “release compounds” that cause inflammation. It goes on to briefly describe senescent cells and the role it plays in medications.
The article covers subjects relating to the aging process. Topics include cellular atrophy, extracellular matrix, and a discussion about improvements to the mitochondria. The article ends with Mr. Hope’s educational and entrepreneurial background.